Logo image of CO.PA

CASINO GUICHARD PERRACHON (CO.PA) Stock Fundamental Analysis

EPA:CO - Euronext Paris - Matif - FR001400OKR3 - Common Stock - Currency: EUR

0.589  -0.01 (-1.09%)

Fundamental Rating

1

Overall CO gets a fundamental rating of 1 out of 10. We evaluated CO against 25 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of CO have multiple concerns. CO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CO had negative earnings in the past year.
CO had a negative operating cash flow in the past year.
CO had negative earnings in each of the past 5 years.
In multiple years CO reported negative operating cash flow during the last 5 years.
CO.PA Yearly Net Income VS EBIT VS OCF VS FCFCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

CO's Return On Assets of -3.57% is on the low side compared to the rest of the industry. CO is outperformed by 76.00% of its industry peers.
CO's Return On Equity of -24.67% is on the low side compared to the rest of the industry. CO is outperformed by 84.00% of its industry peers.
Industry RankSector Rank
ROA -3.57%
ROE -24.67%
ROIC N/A
ROA(3y)-11.81%
ROA(5y)-8.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CO.PA Yearly ROA, ROE, ROICCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

The Gross Margin of CO (27.93%) is better than 72.00% of its industry peers.
In the last couple of years the Gross Margin of CO has grown nicely.
The Profit Margin and Operating Margin are not available for CO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.43%
GM growth 5Y2.39%
CO.PA Yearly Profit, Operating, Gross MarginsCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

CO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CO has been increased compared to 1 year ago.
Compared to 5 years ago, CO has more shares outstanding
The debt/assets ratio for CO has been reduced compared to a year ago.
CO.PA Yearly Shares OutstandingCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CO.PA Yearly Total Debt VS Total AssetsCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

CO has an Altman-Z score of -0.63. This is a bad value and indicates that CO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.63, CO is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 2.57 is on the high side and indicates that CO has dependencies on debt financing.
CO has a Debt to Equity ratio of 2.57. This is amonst the worse of the industry: CO underperforms 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Altman-Z -0.63
ROIC/WACCN/A
WACC4.27%
CO.PA Yearly LT Debt VS Equity VS FCFCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

CO has a Current Ratio of 0.82. This is a bad value and indicates that CO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.82, CO is doing worse than 68.00% of the companies in the same industry.
A Quick Ratio of 0.62 indicates that CO may have some problems paying its short term obligations.
CO's Quick ratio of 0.62 is in line compared to the rest of the industry. CO outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.62
CO.PA Yearly Current Assets VS Current LiabilitesCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

1

3. Growth

3.1 Past

CO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.99%, which is quite impressive.
CO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.81%.
Measured over the past years, CO shows a very negative growth in Revenue. The Revenue has been decreasing by -24.68% on average per year.
EPS 1Y (TTM)99.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.98%
Revenue 1Y (TTM)-36.81%
Revenue growth 3Y-34.92%
Revenue growth 5Y-24.68%
Sales Q2Q%-52.07%

3.2 Future

Based on estimates for the next years, CO will show a very negative growth in Earnings Per Share. The EPS will decrease by -44.95% on average per year.
Based on estimates for the next years, CO will show a decrease in Revenue. The Revenue will decrease by -0.13% on average per year.
EPS Next Y-133.84%
EPS Next 2Y-44.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.79%
Revenue Next 2Y-0.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CO.PA Yearly Revenue VS EstimatesCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B 50B
CO.PA Yearly EPS VS EstimatesCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 200 -200 400

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CO.PA Price Earnings VS Forward Price EarningsCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

60.00% of the companies in the same industry are cheaper than CO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.19
CO.PA Per share dataCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

CO's earnings are expected to decrease with -44.95% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.95%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASINO GUICHARD PERRACHON

EPA:CO (5/5/2025, 12:50:07 PM)

0.589

-0.01 (-1.09%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)04-22 2025-04-22
Earnings (Next)07-28 2025-07-28
Inst Owners9.39%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap236.15M
Analysts36
Price Target1.84 (212.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB N/A
EV/EBITDA 11.19
EPS(TTM)-0.68
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-3.38
FCFYN/A
OCF(TTM)-2.63
OCFYN/A
SpS21.35
BVpS2.98
TBVpS-3.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.57%
ROE -24.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.93%
FCFM N/A
ROA(3y)-11.81%
ROA(5y)-8.02%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.43%
GM growth 5Y2.39%
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF N/A
Debt/EBITDA 9.33
Cap/Depr 48%
Cap/Sales 3.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.62
Altman-Z -0.63
F-Score3
WACC4.27%
ROIC/WACCN/A
Cap/Depr(3y)73.9%
Cap/Depr(5y)74.96%
Cap/Sales(3y)8.16%
Cap/Sales(5y)6.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.98%
EPS Next Y-133.84%
EPS Next 2Y-44.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.81%
Revenue growth 3Y-34.92%
Revenue growth 5Y-24.68%
Sales Q2Q%-52.07%
Revenue Next Year-0.79%
Revenue Next 2Y-0.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year253.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.09%
OCF growth 3YN/A
OCF growth 5YN/A